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Summary
Objective: To investigate the relationship between obstructive sleep apnea (OSA)
and the metabolic syndrome, an established cardiovascular risk factor, in middle-
aged Chinese subjects.
Design: A prospective cross-sectional study from community-dwelling volunteers.ee front matter & 2005
med.2005.10.003
ing author. Tel.: +852 28
ess: msmip@hkucc.hku.Subjects: Subjects of either sex between 30 and 60 years old were recruited from
the staff in public institutions or visitors to community centers in Hong Kong.
Methods: Demographic and anthropomentric indices, blood pressure and metabolic
profile (fasting blood glucose, total cholesterol, low-density lipoprotein-cholesterol,
high-density lipoprotein-cholesterol and triglycerides) were measured. Overnight
polysomnographic studies were conducted. Presence of obstructive sleep apnea
(OSA) was defined as apnea–hypopnea index (AHI)X5. Metabolic syndrome was
defined by the criteria of the National Cholesterol Education Panel, but using Asian
cut-off values for abdominal obesity.
Results: A total of 255 subjects (150 men, 105 women) were studied. Subjects with
OSA had five-fold risk of having metabolic syndrome. OSA was associated with the
metabolic syndrome or its components, including waist circumference, diastolic
blood pressure and fasting glucose, after adjusting for confounding variables. The
independent determinants of OSA were age, gender, body mass index (BMI) and the
metabolic syndrome.Elsevier Ltd. All rights reserved.
55 4605; fax: +852 2816 2863.
hk (M.S.M. Ip).
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OSA and the metabolic syndrome in community-based Chinese adults 981Conclusion: Among community-based middle-aged Chinese subjects, the metabolic
syndrome was independent predictor of OSA.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Obstructive sleep apnea (OSA) has been associated
with increased cardiovascular and cerebrovascular
morbidity and mortality, and there is growing
evidence of an independent contribution of OSA
towards this, although much of the causal role and
mechanisms are still being unraveled.1,2 The
hypothesized link between OSA and cardiovascular
disease (CVD) is complex and likely involves
interactions of pathophysiologic mechanisms in
sleep-disordered breathing with various metabolic
risk factors for CVD.
The clustering of several metabolic and morpho-
logic features in the metabolic syndrome including
insulin resistance or glucose intolerance, dyslipide-
mia, hypertension and abdominal obesity is well
recognized as a risk factor for CVD.3 It has long
been observed in clinical practice that OSA is highly
associated with various features of the metabolic
syndrome, in particular, obesity.4,5 Research has
focused on the association between OSA and
individual components of the metabolic syndrome
independent of obesity, and there is now good
evidence to support an independent adverse effect
of OSA on hypertension,6,7 while evidence on other
factors is also increasing. The Sleep Heart Health
Study, a cross-sectional epidemiologic study of over
6000 middle-aged subjects in the USA, reported on
the association of sleep-disordered breathing and a
number of cardiovascular risk factors, including
parameters in the metabolic syndrome.8 Recently,
a European study comparing male OSA subjects
from a sleep clinic with controls without OSA
showed independent associations between OSA
and the metabolic syndrome as well as its compo-
nents.9
In Chinese subjects, despite the lesser severity of
obesity compared with non-Asian populations,
obesity has also been demonstrated to be a major
risk factor for OSA.10,11 Recently, the World Health
Organization (WHO) has recommended lower
threshold values for definitions of obesity and
abdominal obesity and for intervention of obesity-
related diseases in the Asian population.12,13 We
have also observed in clinic populations that OSA is
highly associated with the features seen in the
metabolic syndrome.14 The aim of this prospective
study was to investigate the relationship between
OSA and the metabolic syndrome or its componentsin a cohort of middle-aged community-based
Chinese adults in Hong Kong.Methods
Subjects and protocol
This study was part of a territory-wide community-
based project investigating the epidemiology of
sleep-disordered breathing in middle-aged (30–60
years) Chinese adults in Hong Kong. Subjects were
recruited from staff in public institutions and
visitors to community centers, and those who had
participated in a study on the prevalence of sleep-
disordered breathing in Chinese in Hong Kong, the
methodology and results of which have been
reported previously.10,11 The public institutions
were government departments for non-health-
related functions, while the community centers
were operated by non-government organizations
that provided a variety of welfare activities. A
questionnaire on demographics, sleep symptoms
and medical history was completed. Subjects who
agreed to undergo in-laboratory polysomnograms
(PSG) comprised the cohort investigated in this
study. Anthropometric indices were taken, and
fasting blood samples for metabolic parameters
were collected in the morning after the sleep study.
The study was approved by the Ethics Committee of
The University of Hong Kong and all subjects gave
their written informed consent.
Polysomnography
Subjects underwent an overnight 16-channel PSG
(Alice 3 system; Respironics, Pittsburgh, PA) at the
Sleep Laboratory, Queen Mary Hospital, as de-
scribed previously.10,11 PSG recordings were manu-
ally scored according to standard criteria.15–17 OSA
was defined by an apnea–hypopnea index (AHI)X5.
Anthropometric and biochemical
measurements
Body weight and height were measured (Detecto
scale, MO, USA) in bare feet and light clothing in
the morning. Body mass index (BMI) was defined as
weight (kg)/height2 (m). Waist circumference was
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costal margin and the iliac crest.18 Blood pressure
was measured with Dinamap (Critikon Inc., Florida)
and the average of three readings taken at a 1-min
interval was documented.
Fasting blood was taken in the morning for
estimation of serum glucose and lipid profile
comprising total cholesterol, high-density lipopro-
tein (HDL)-cholesterol, low-density lipoprotein
(LDL)-cholesterol and triglycerides. Fasting blood
glucose was measured by the glucose oxidase
method on a Beckman autoanalyzer (Beckman
Instruments, Bream, CA). Total cholesterol, trigly-
cerides and HDL-cholesterol concentrations were
measured using an immunocolorimetric assay on an
ADVIA 1650 chemistry system (Bayer Corporation,
Tarrytown, NY, USA). LDL-cholesterol was derived
using the Friedwald equation.Definition of the metabolic syndrome
The definition of the metabolic syndrome was
based on the clinical diagnostic criteria of the
Third Report of the National Cholesterol Education
Program (NCEP),19 as the presence of three or more
of the following five risk factors: hypertension as
defined by a history of hypertension and taking
anti-hypertensive drugs, or a recorded systolic
blood pressureX130mmHg or diastolic blood pres-
sure X85mmHg; insulin resistance or glucose
intolerance as defined by a history of diabetes
mellitus and receiving drug treatment, or a fasting
blood glucose concentration X6.1mmol/L; HDL-
cholesterol in men o1.03mmol/L or in women
o1.29mmol/L; a serum total triglyceride concen-
tration X1.69mmol/L; and abdominal obesity as
defined by waist circumference according to the
recommended criteria for Asians, atX90 cm in men
andX80 cm in women. These threshold criteria for
abdominal obesity were recommended by WHO12
and have been subsequently validated in Asians or
southern Chinese populations in Singapore and
Hong Kong, respectively.20,21 Obesity was defined
at BMIX 25, as recommended for Asians.12 We also
accepted two subjects on lipid-lowering drugs as
fulfilling the criteria for hyperlipidemic para-
meters.Data analysis
Descriptive statistics were used to summarize
subject characteristics and questionnaire data.
Continuous variables were expressed as mean
values7SD. The primary study parameter, OSA,
was used as the dependent categorical variable inall analyses. Those data that were not normally
distributed were log-transformed before analysis.
Comparisons between OSA and non-OSA groups of
baseline characteristics were made with the Stu-
dent’s t-test for continuous variables, while cate-
gorical variables were assessed by the Chi-square
test and analysis of variance. Correlations between
OSA and metabolic variates were evaluated with
the Pearson’s correlation test, after excluding
those on drug treatment, for the relevant meta-
bolic condition.
In order to determine whether the associations
between OSA and the individual metabolic para-
meters were independent of obesity and other
known covariates, logistic regression analysis was
performed, adjusted for age, gender, BMI, smoking
and alcohol consumption. The independent vari-
ables were: age, gender, BMI, smoking, alcohol
consumption, and the metabolic syndrome entity.
The interactions between the metabolic syndrome
and age, BMI, and gender, respectively, were
considered in the regression analysis to assess the
strength of the associations. A P-value of o0.05
was considered to indicate statistical significance.
Statistical analyses were performed with SPSS for
Windows software (version 12.0).Results
Of 1612 questionnaire respondents 259 (16%)
subjects came for PSG. Four were rejected due to
insufficient sleep time (o4 h sleep time) in 3, and a
technical fault in 1, recordings. Thus, 255 subjects
(150 men, 105 women) had data for both sleep
parameters and metabolic profile. Compared to BMI
data obtained in a community study of over 7000
subjects in Hong Kong (22), the men in our study
had a slightly higher BMI (mean age 41.8 years with
a mean BMI of 25.9 vs. 40–44 years old with a mean
BMI 24.4), while women had comparable BMI (mean
age 44.3 years with a mean BMI of 24.3 vs. 40–49
years old with a mean BMI of 24.3). Self-reported
history of relevant medical diseases on treatment
was: hypertension: 33; diabetes mellitus: 18; and
hyperlipidemia: 2. There were 17 (6.7%) current
smokers, 11 (4.3%) current alcoholic drinkers
(defined as regularly drinking more than 3 days a
week).
Of 255 participants, 95 (37%) were found to have
an AHIX5 and 160 (63%) had an AHI o5. Table 1
shows that subjects with OSA had a significantly
worse metabolic profile compared to those without
OSA.
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Table 1 Clinical parameters in all subjects according to OSA status.
AHIo5 AHIX5 P-value
Number of subjects 160 95
Male (number (%)) 86 (54) 64 (67) 0.033
Age (years) 41.6 (6.4) 45.1 (6.9) o0.001
Body mass index 24.0 (3.1) 27.2 (3.3) o0.001
Waist circumference (cm)
Male (no. of subjects (63:85)) 88.0 (6.8) 93.3 (6.9) o0.001
Female (no. of subjects (31:74)) 77.4 (9.3) 85.5 (10.8) o0.001
Systolic blood pressure (mmHg) 122 (15) 131 (15) o0.001
Diastolic blood pressure (mmHg) 72 (13) 80 (13) o0.001
Total cholesterol (mmol/L) 4.8 (1.0) 5.2 (1.1) 0.018
Triglycerides (mmol/L) 1.1 (0.7–1.7) 1.6 (1.1–2.3) o0.001
LDL-cholesterol (mmol/L) 3.1 (0.8) 3.2 (0.8) NS
HDL-cholesterol (mmol/L) 1.2 (0.3) 1.1 (0.3) 0.009
T. cholesterol/HDL-cholesterol 4.1 (1.1) 4.8 (1.5) o0.001
Fasting glucose (mmol/L) 5.1 (0.6) 5.5 (0.9) 0.001
Apnea–hypopnea index 2.5 (1.3) 19.7 (13.6)
Minimum oxygen saturation (%) 89.5 (6.0) 76.1 (10.6)
Duration of oxygen saturationo90% (min) 1.7 (5.6) 24.7 (40.2)
Arousal index 15.9 (12.5) 19.9 (16.3)
Data are presented as mean (SD) unless otherwise stated.
AHI ¼ apnea–hypopnea index, LDL-cholesterol ¼ low-density lipoprotein-cholesterol, HDL-cholesterol ¼ high-density lipopro-
tein-cholesterol, T. cholesterol/HDL-cholesterol ¼ Total cholesterol/high-density lipoprotein-cholesterol.
Median (interquartile range) is presented and logarithmic transformed (log (1+triglycerides)) before analysis.By the
independent sample t-test.
Table 2 Clinical identification of the metabolic syndrome.
(%) Fulfilling metabolic criteria
Metabolic parameters AHIo5
(n ¼ 160)
AHIX5
(n ¼ 95)
Odds ratio (CI) P-value
Waist circumference 60 (38) 63 (66) 3.3 (1.9–5.6) o0.001
Systolic blood pressure 56 (35) 53 (56) 2.41(1.43–4.08) 0.001
Diastolic blood pressure 34 (21) 42 (44) 3.0 (1.72–5.25) o0.001
HDL-cholesterol 72 (45) 60 (63) 2.1 (1.25–3.53) 0.006
Triglycerides 40 (25) 42 (44) 2.4 (1.39–4.08) 0.002
Fasting glucose 15 (9) 22 (23) 2.9 (1.43–5.95) 0.003
Metabolic syndrome (Any 3 risk factors or more) 33 (21) 55 (58) 5.3 (3.03–9.26) o0.001
Number of subjects (% in the group).
By the Chi-square test.
Table 3 Association of OSA and the metabolic syndrome (stratified by AHI).
AHI o5 5–14.9 15–29.9 X30
Number of subjects 160 48 27 20 P-value
Metabolic syndrome, number (%) 33 (21) 26 (54) 15 (56) 14 (70) 0.001
Number of subjects (% in the group).
By analysis of variance.
OSA and the metabolic syndrome in community-based Chinese adults 983Of 255 subjects, 88 (34.5%) fulfilled the criteria
of metabolic syndrome. Fifty-five of these 88
subjects (62.5%) with the metabolic syndrome hadOSA, while only 40 of 167 (24%) subjects without
the metabolic syndrome had OSA (62.5% vs. 24%,
Po0:001). Subjects with OSA had a 5-fold risk of
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Table 4 Associations between obstructive sleep apnea and the metabolic syndrome and its components
(n ¼ 255).
Dependent variable Obstructive sleep apnea
Odds ratio (95% CI) P-value
Waist circumference 3.56 (2.02–6.29) o0.001
Systolic blood pressurey 1.47 (0.79–2.71) NS
Diastolic blood pressurey 2.04 (1.06–3.92) 0.034
HDL-cholesteroly 1.29 (0.68–2.46) NS
Triglyceridesy 1.42 (0.76–2.66) NS
Fasting glucosey 2.74 (1.16–6.49) 0.022
Metabolic syndromey (Any 3 risk factors or more) 2.65 (1.38–5.08) 0.003
Metabolic variables were defined according to NCEP cut-off values (except waist circumference as recommended for Asians by
WHO).
Interactions between the metabolic syndrome and gender, age, and BMI were considered.
Adjusted for age, gender, history of smoking and alcohol consumption.
yAdjusted for age, gender, BMI, history of smoking and alcohol consumption.
Table 5 Regression model: the metabolic syn-
drome as an independent determinant of obstruc-
tive sleep apnea.
Dependent variable Obstructive sleep apnea
Odds
ratio
(95% CI) P-value
Gender 0.51 0.27–0.98 0.044
Age (year)y 1.10 1.05–1.15 o0.001
BMI (kg/m2)y 1.30 1.17–1.45 o0.001
Metabolic syndrome 2.62 1.37–4.50 0.004
Independent variables: age, gender, body mass index,
history of smoking and alcohol consumption and the
metabolic syndrome were considered.
By stepwise logistic regression analysis.
Female gender was an independent factor for a lower
risk of obstructive sleep apnea.
yAge and BMI were analyzed as continuous variables and
the odds ratios reflected the risk associated with each
incremental year of age and unit of BMI, respectively.
J.C.M. Lam et al.984having the metabolic syndrome (OR 5.3, CI
3.03–9.26, Po0:001) compared to subjects without
OSA (Table 2).
A linear trend effect of increasing association
with the metabolic syndrome as the severity of
OSA increased in terms of AHI was demonstrated
(Table 3).
On univariate analysis, OSA was significantly
correlated with age (r ¼ 0:259, Po0:001), BMI
(r ¼ 0:449, Po0:001), waist circumference
(r ¼ 0:448, Po0:001), systolic blood pressure
(r ¼ 0:289, Po0:001), diastolic blood pressure
(r ¼ 0:289, Po0:001), triglycerides (r ¼ 0:377,
Po0:001) and HDL-cholesterol (r ¼ 0:237,Po0:001). After adjusting for age, gender, BMI
(except for analysis of waist circumference) and
history of smoking and alcohol consumption,
independent associations were observed between
OSA and the following variables: waist circumfer-
ence, diastolic blood pressure, fasting glucose
concentration and the metabolic syndrome. Analy-
sis of the influence of age, BMI or gender on the
associations between OSA and the metabolic
syndrome or its components did not reveal any
substantial effect (Table 4).
In the stepwise logistic regression models, the
independent determinants of OSA were age, gen-
der, BMI, and the metabolic syndrome in our study
population (Table 5).Discussion
This study is the first to address the relationship
between the metabolic syndrome and sleep-
disordered breathing in a group of community-
based Asian subjects, using overnight polysomno-
graphy objectively and measured metabolic para-
meters. Those with OSA had 5-times more
likelihood of suffering from the metabolic syn-
drome and vice versa. The metabolic syndrome and
several of its components were independently
associated with OSA.
Obesity and abdominal obesity are established
risk factors for OSA23,24 while abdominal obesity is
known to play an important role in the develop-
ment of insulin resistance and the metabolic
syndrome.3,25,26 Thus, abdominal obesity plays a
pivotal role in the link between OSA and the
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effect of obesity, previous studies have shown that
there is an independent association between OSA
and other parameters of the metabolic syndrome
such as hypertension28–30 and insulin resis-
tance.27,31–34
There is a consensus of evidence to support that
OSA has an adverse effect on elevation of blood
pressure and OSA patients have an increased risk of
hypertension, independent of obesity and age.28–30
This was again illustrated in the independent
association of OSA and elevated diastolic blood
pressure in this cohort study. It has been well
demonstrated in previous studies that the diastolic
blood pressure was more strongly associated with
OSA14,28,32 and the observed decrease in 24-h
diastolic blood pressure was greater after contin-
uous positive airway pressure (CPAP) treatment, as
compared to systolic blood pressure.35
Subjects with diabetes mellitus are often obese
and they have been shown to have a high
prevalence of OSA.31 Although the relationship
between insulin resistance and OSA has not been
fully delineated yet, there is accumulating evi-
dence to support the fact that OSA is associated
with insulin resistance, independent of obe-
sity,27,32,33 and treatment of OSA has been reported
to improve insulin sensitivity.34 Consistent with
these previous findings, we demonstrated a sig-
nificant association between fasting blood glucose
and OSA, independent of confounding variables.
The relationships between OSA and various lipid
parameters have not been as extensively investi-
gated as that of other components in the metabolic
syndrome and the results have been more diverse.
The American Heart Health Sleep Study reported
that AHI was inversely related to HDL-cholesterol
levels in younger men and women, but not in older
men, and triglyceride levels in younger men and
women only.8 Studies of sleep clinic cohorts have
consistently reported a higher prevalence of
dyslipidemia in OSA subjects compared to those
without OSA,14,36,37 including a recent study of
Caucasian men, which reported an independent
association between increased triglyceride concen-
trations, decreased HDL-cholesterol levels, and
increased total cholesterol:HDL-cholesterol ratio.9
An association between the number of apolipopro-
tein E4 alleles, a gene leading to higher LDL-
cholesterol levels has also been reported, while the
severity of OSA was associated with higher levels of
LDL-cholesterol.38 The treatment of OSA was
reported to result in a decrease of total cholesterol
levels.37 In this study, although there were correla-
tions between OSA and the lipid levels, the
associations did not manifest when controlled forconfounding variables, and we did not identify an
association between OSA and the lipid syndrome-
defining parameters.
Compared to the relationships between OSA and
various individual metabolic variates, there are
much less data in the literature regarding the
relationship between OSA and the metabolic
syndrome entity. The European study of Caucasian
men with OSA reported a nine-fold risk for the
metabolic syndrome,9 while Chinese men in this
study demonstrated a lower association at a five-
fold risk. Similar to their findings, an independent
association between the metabolic syndrome and
sleep-disordered breathing was seen. The Cauca-
sian study comprised OSA subjects who were
recruited from sleep clinics while our recruitment
was targeted at community-based subjects. Sleep
clinic subjects have inherent referral bias for those
with features of both sleep apnea and obesity with
or without an obesity-related metabolic profile,
thus predisposing towards a higher association,39
while this tendency would be less in community-
based recruitment, although self-selection bias for
study participation could not be eliminated. Our
subjects came for sleep study on a voluntary basis,
and those who believed they were more likely to
have sleep apnea (usually those who were more
obese) tended to come. On comparing the BMI of
age-matched subjects from a previous large-scale
study in the local community,22 the men in our
study were only slightly more obese while women
had similar BMIs. Thus, the effect of self-selection
bias was probably not significant. The discrepancy
in the degree of association between OSA and the
metabolic syndrome reported in the two studies
may also be due to variations in genetic or
environmental predisposition to either condition
in these two cohorts of different ethnicity and
locality.
There is ongoing research to understand the
genetics of OSA, and initial work has focused on the
search for genetic loci contributing to OSA and its
associated phenotypes such as obesity. In a geno-
mewide scan for OSA genes, there was some
evidence of a linkage to AHI and BMI on chromo-
some 2p in white American subjects. This region
coincides with the loci for propiomelanocortin
(POMC), a hormone which is known to be closely
connected to obesity and related phenotypes.40 It
is plausible, although highly postulative at this
point of our knowledge, that the genetic determi-
nants of OSA and the metabolic syndrome may be
closely linked to each other. On the other hand,
OSA is characterized by increased sympathetic
output and other pathophysiological mechanisms
that may provide an independent predisposition to
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through aggravation of some of these metabolic risk
factors,41,42 resulting in an independent associa-
tion. Our findings highlight the importance of a high
index of suspicion for OSA in Chinese subjects with
the metabolic syndrome and vice versa. Prompt
recognition and effective treatment of co-existent
risk factors may reduce cardiovascular morbidity
and mortality, and concerted community and
professional efforts on appropriate lifestyle beha-
vioral modifications should be propagated.Acknowledgements
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